Evogene (EVGN) Reports Q1 Loss of $0.13/Share

Evogene (NYSE: EVGN) reported Q1 EPS of ($0.13), versus ($0.13) reported last year. Revenue for the quarter came in at $2 million, versus $2.7 million reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• SanDisk upgraded at JPMorgan after investor day; shares climb